{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-288343","form_type":"8-K","ticker":"OLMA","cik":"0001750284","company_name":"Olema Pharmaceuticals, Inc.","filed_at":"2025-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.338763+00:00","generated_at":"2026-05-16T18:30:56.955131+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Olema Pharmaceuticals announces $190M follow-on offering of 10M shares at $19.00","bullets":["Offering of 10,000,000 shares of common stock at $19.00 per share for gross proceeds of ~$190M.","Underwriters have a 30-day option to purchase up to 1,500,000 additional shares.","Closing expected on November 20, 2025, subject to customary conditions.","Underwriting agreement with TD Securities (USA) LLC as representative of the underwriters."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-288343","json":"https://secwatch.observer/filing/0001193125-25-288343.json","markdown":"https://secwatch.observer/filing/0001193125-25-288343.md","text":"https://secwatch.observer/filing/0001193125-25-288343.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750284/000119312525288343/0001193125-25-288343-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750284/000119312525288343/d46182d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:30:56.955131+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}